VRPX: Virpax Pharmaceuticals Inc. Stocks News on November 18, 2024

VRPX

Business Wire

3 days ago

Virpax Pharmaceuticals, Inc. Announces Closing of $5.0 Million Public Offering of Common Stock and Pre-Funded Warrants

VRPX

Business Wire

5 days ago

Virpax Pharmaceuticals, Inc. Announces Pricing of $5.0 Million Public Offering of Common Stock and Pre-Funded Warrants

Adial Pharmaceuticals Appoints Vinay Shah as Chief Financial Officer

VRPX

GlobeNewswire

13 days ago

Adial Pharmaceuticals Appoints Vinay Shah as Chief Financial Officer

Virpax Pharmaceuticals Reports 2024 Second Quarter Results and Recent Developments

VRPX

Business Wire

3 months ago

Virpax Pharmaceuticals Reports 2024 Second Quarter Results and Recent Developments

Virpax Pharmaceuticals to Present at Sidoti Virtual Investor Conference August 14-15

VRPX

Business Wire

3 months ago

Virpax Pharmaceuticals to Present at Sidoti Virtual Investor Conference August 14-15

Virpax Regains Compliance with Nasdaq Minimum Bid Price

VRPX

Business Wire

4 months ago

Virpax Regains Compliance with Nasdaq Minimum Bid Price

Pain Management-Focused Penny Stock Virpax Pharmaceuticals Surges Over 100% On Wednesday-Here's Why?

VRPX

Benzinga

4 months ago

Pain Management-Focused Penny Stock Virpax Pharmaceuticals Surges Over 100% On Wednesday-Here's Why?

VRPX

MT Newswires

4 months ago

Virpax Says Non-Narcotic Pain Medication Shows Positive Results in Swine Model Study; Shares Rise

Virpax Announces Positive Results of Swine Model Pilot Study for Probudur™

VRPX

Business Wire

4 months ago

Virpax Announces Positive Results of Swine Model Pilot Study for Probudur™

Virpax Pharmaceuticals Secures $2.5 Million Loan Financing and an Agreement with an Institutional Investor to Negotiate Additional Funding

VRPX

Business Wire

4 months ago

Virpax Pharmaceuticals Secures $2.5 Million Loan Financing and an Agreement with an Institutional Investor to Negotiate Additional Funding

Virpax® Pharmaceuticals to Present at 2024 BIO International Convention

VRPX

Business Wire

6 months ago

Virpax® Pharmaceuticals to Present at 2024 BIO International Convention

VRPX

MT Newswires

6 months ago

Virpax Prices Public Offering of Shares, Warrants; Shares Tumble

VRPX

MT Newswires

6 months ago

Top Premarket Decliners

Virpax Announces Pricing of $2.25 Million Public Offering

VRPX

Business Wire

6 months ago

Virpax Announces Pricing of $2.25 Million Public Offering

Virpax Pharmaceuticals Reports 2024 First Quarter Results and Recent Developments

VRPX

Business Wire

6 months ago

Virpax Pharmaceuticals Reports 2024 First Quarter Results and Recent Developments

Virpax Announces Results of Maximum Tolerated Dose Study for Probudur™

VRPX

Business Wire

7 months ago

Virpax Announces Results of Maximum Tolerated Dose Study for Probudur™

Virpax Pharmaceuticals Reports 2023 Year-End Results

VRPX

Business Wire

8 months ago

Virpax Pharmaceuticals Reports 2023 Year-End Results

Virpax Pharmaceuticals Announces Reverse Stock Split to Regain Compliance with Nasdaq’s Minimum Bid Price

VRPX

Business Wire

9 months ago

Virpax Pharmaceuticals Announces Reverse Stock Split to Regain Compliance with Nasdaq’s Minimum Bid Price

Virpax Pharmaceuticals Announces Proposed Settlement of Litigation with Sorrento Therapeutics, Inc. and Scilex Pharmaceuticals, Inc.

VRPX

Business Wire

9 months ago

Virpax Pharmaceuticals Announces Proposed Settlement of Litigation with Sorrento Therapeutics, Inc. and Scilex Pharmaceuticals, Inc.

Virpax Pharmaceuticals Announces Preliminary Results of ProbudurTM Pilot Study with the U.S. Army Institute of Surgical Research

VRPX

Business Wire

9 months ago

Virpax Pharmaceuticals Announces Preliminary Results of ProbudurTM Pilot Study with the U.S. Army Institute of Surgical Research

SRM Entertainment Showcases New Products at the 2024 Las Vegas Winter Market Gift Show

VRPX

GlobeNewswire

10 months ago

SRM Entertainment Showcases New Products at the 2024 Las Vegas Winter Market Gift Show

Best Momentum Stocks to Buy for January 26th

VRPX

Zacks

10 months ago

Best Momentum Stocks to Buy for January 26th

WISeKey Joins Global Mergers, Acquisitions & Investment Council (GMAIC)

VRPX

GlobeNewswire

10 months ago

WISeKey Joins Global Mergers, Acquisitions & Investment Council (GMAIC)

Maxim Group LLC to Host the 2024 Healthcare IT Virtual Conference on Wednesday, January 24th & Thursday, January 25th at 9:00 A.M. ET

VRPX

GlobeNewswire

10 months ago

Maxim Group LLC to Host the 2024 Healthcare IT Virtual Conference on Wednesday, January 24th & Thursday, January 25th at 9:00 A.M. ET

VRPX

GlobeNewswire

10 months ago

SurgePays Acquires ClearLine Mobile

Are You Looking for a Top Momentum Pick? Why BTCS Inc. (BTCS) is a Great Choice

VRPX

Zacks

10 months ago

Are You Looking for a Top Momentum Pick? Why BTCS Inc. (BTCS) is a Great Choice

CervoMed to Participate in the Emerging Growth Conference 66

VRPX

GlobeNewswire

10 months ago

CervoMed to Participate in the Emerging Growth Conference 66

Eco Wave Power Commences Sending of Clean Electricity to the Israeli National Electrical Grid

VRPX

PR Newswire

10 months ago

Eco Wave Power Commences Sending of Clean Electricity to the Israeli National Electrical Grid

New Study Reports IceCure's ProSense® Boosts Immune Response Against Cancer: Enhances CD8+ T Cell Response

VRPX

PR Newswire

10 months ago

New Study Reports IceCure's ProSense® Boosts Immune Response Against Cancer: Enhances CD8+ T Cell Response

Asensus Surgical, Inc. to Present at the 42nd Annual J.P. Morgan Healthcare Conference

VRPX

GlobeNewswire

10 months ago

Asensus Surgical, Inc. to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Pasithea Therapeutics Announces FDA Acceptance of IND Application to Evaluate PAS-004 in Advanced Cancer Patients

VRPX

GlobeNewswire

a year ago

Pasithea Therapeutics Announces FDA Acceptance of IND Application to Evaluate PAS-004 in Advanced Cancer Patients

Virpax Pharmaceuticals Announces Results of Special Shareholders Meeting

VRPX

Business Wire

a year ago

Virpax Pharmaceuticals Announces Results of Special Shareholders Meeting

Alterity Therapeutics Appoints Phillip Hains as Chief Financial Officer

VRPX

GlobeNewswire

a year ago

Alterity Therapeutics Appoints Phillip Hains as Chief Financial Officer

Inpixon Announces That Damon Motors Will Feature Its HyperFighter Superbike at CES 2024

VRPX

PR Newswire

a year ago

Inpixon Announces That Damon Motors Will Feature Its HyperFighter Superbike at CES 2024

Aclaris Therapeutics Provides Corporate Update

VRPX

GlobeNewswire

a year ago

Aclaris Therapeutics Provides Corporate Update

Cepton Inc's Chief Commercial Officer Reveals Cost-Efficient Innovations and Strategic Partnerships

VRPX

News Direct

a year ago

Cepton Inc's Chief Commercial Officer Reveals Cost-Efficient Innovations and Strategic Partnerships

Take Care Before Diving Into The Deep End On Concord Medical Services Holdings Limited (NYSE:CCM)

VRPX

Simply Wall St.

a year ago

Take Care Before Diving Into The Deep End On Concord Medical Services Holdings Limited (NYSE:CCM)

Veru Announces Pricing of Public Offering of Common Stock

VRPX

GlobeNewswire

a year ago

Veru Announces Pricing of Public Offering of Common Stock

$Bio-Path Holdings Successfully Completes First Dose Cohort of Phase 1/1b Clinical Trial of BP1002 in Refractory/Relapsed Acute Myeloid Leukemia$

VRPX

GlobeNewswire

a year ago

Bio-Path Holdings Successfully Completes First Dose Cohort of Phase 1/1b Clinical Trial of BP1002 in Refractory/Relapsed Acute Myeloid Leukemia

Study Using IceCure's ProSense® Finds: "Cryoablation Allows the Ultimate De-escalation of Surgical Therapy for Select Breast Cancer Patients"

VRPX

PR Newswire

a year ago

Study Using IceCure's ProSense® Finds: "Cryoablation Allows the Ultimate De-escalation of Surgical Therapy for Select Breast Cancer Patients"

Pennsylvania-based Health System Expands Relationship With Streamline Health® eValuator™ Pro-Fee Module

VRPX

GlobeNewswire

a year ago

Pennsylvania-based Health System Expands Relationship With Streamline Health® eValuator™ Pro-Fee Module

Solitario CEO to Present at John Tumazos Very Independent Research, LLC Virtual Conference

VRPX

ACCESSWIRE

a year ago

Solitario CEO to Present at John Tumazos Very Independent Research, LLC Virtual Conference

Mustang Bio Presents Updated Phase 1/2 Multicenter Clinical Data for MB-106 at the 2023 American Society of Hematology (ASH) Annual Meeting

VRPX

GlobeNewswire

a year ago

Mustang Bio Presents Updated Phase 1/2 Multicenter Clinical Data for MB-106 at the 2023 American Society of Hematology (ASH) Annual Meeting

Altisource Asset Management Corporation Announces Departure of COO and Interim CEO Danya Sawyer

VRPX

Business Wire

a year ago

Altisource Asset Management Corporation Announces Departure of COO and Interim CEO Danya Sawyer

Alterity (ATHE) Up on Preclinical Parkinson's Treatment Data

VRPX

Zacks

a year ago

Alterity (ATHE) Up on Preclinical Parkinson's Treatment Data

Leading Tier 1 European Mobile Operator Signs New SafePath® Multiyear Contract with Smith Micro

VRPX

Business Wire

a year ago

Leading Tier 1 European Mobile Operator Signs New SafePath® Multiyear Contract with Smith Micro

Alterity Therapeutics to Host Webcast to Discuss ATH434 Efficacy Data in Primates and Recent Clinical Progress

VRPX

GlobeNewswire

a year ago

Alterity Therapeutics to Host Webcast to Discuss ATH434 Efficacy Data in Primates and Recent Clinical Progress

Altisource Asset Management Corporation Reports Receipt of Communications from NYSE

VRPX

Business Wire

a year ago

Altisource Asset Management Corporation Reports Receipt of Communications from NYSE

Daré Bioscience Announces Commencement of Phase 3 Study of Ovaprene®, an Investigational Hormone-Free Monthly Intravaginal Contraceptive

VRPX

GlobeNewswire

a year ago

Daré Bioscience Announces Commencement of Phase 3 Study of Ovaprene®, an Investigational Hormone-Free Monthly Intravaginal Contraceptive

CMS Posts Final Payment Determination for bioAffinity Technologies’ CyPath® Lung Effective January 2024

VRPX

Business Wire

a year ago

CMS Posts Final Payment Determination for bioAffinity Technologies’ CyPath® Lung Effective January 2024

Rallybio Announces Preliminary Multiple Dose Data from the Completed Phase 1 Safety and Pharmacokinetics Study for RLYB212, an Anti-HPA-1a Monoclonal Antibody for the Prevention of Fetal and Neonatal Alloimmune Thrombocytopenia

VRPX

Business Wire

a year ago

Rallybio Announces Preliminary Multiple Dose Data from the Completed Phase 1 Safety and Pharmacokinetics Study for RLYB212, an Anti-HPA-1a Monoclonal Antibody for the Prevention of Fetal and Neonatal Alloimmune Thrombocytopenia

VRPX

Associated Press Finance

a year ago

Bright Scholar: Fiscal Q4 Earnings Snapshot

VRPX

PR Newswire

a year ago

Bright Scholar Announces Unaudited Financial Results for the Fourth Fiscal Quarter and Fiscal Year 2023

Remark Holdings, Inc. (NASDAQ:MARK) Q3 2023 Earnings Call Transcript

VRPX

Insider Monkey

a year ago

Remark Holdings, Inc. (NASDAQ:MARK) Q3 2023 Earnings Call Transcript

Bio-Path Holdings, Inc. (NASDAQ:BPTH) Q3 2023 Earnings Call Transcript

VRPX

Insider Monkey

a year ago

Bio-Path Holdings, Inc. (NASDAQ:BPTH) Q3 2023 Earnings Call Transcript

Virpax Pharmaceuticals Announces Notification from Nasdaq Related to Delayed Form 10-Q Filing

VRPX

Business Wire

a year ago

Virpax Pharmaceuticals Announces Notification from Nasdaq Related to Delayed Form 10-Q Filing

Virpax Pharmaceuticals Announces Leadership Transition

VRPX

Business Wire

a year ago

Virpax Pharmaceuticals Announces Leadership Transition

Astra Announces Third Quarter 2023 Financial Results

VRPX

Business Wire

a year ago

Astra Announces Third Quarter 2023 Financial Results

Several Insiders Invested In SHF Holdings Flagging Positive News

VRPX

Simply Wall St.

a year ago

Several Insiders Invested In SHF Holdings Flagging Positive News

Virpax Pharmaceuticals Reports 2023 Third Quarter Results and Recent Developments

VRPX

Business Wire

a year ago

Virpax Pharmaceuticals Reports 2023 Third Quarter Results and Recent Developments

VRPX

Thomson Reuters StreetEvents

a year ago

Q3 2023 Kingstone Companies Inc Earnings Call

Dragonfly Energy Reports Third Quarter 2023 Financial and Operational Results

VRPX

GlobeNewswire

a year ago

Dragonfly Energy Reports Third Quarter 2023 Financial and Operational Results

Future FinTech Announces the Closing of the Acquisition of Alpha International Securities (Hong Kong) Ltd.

VRPX

PR Newswire

a year ago

Future FinTech Announces the Closing of the Acquisition of Alpha International Securities (Hong Kong) Ltd.

Bearish: Analysts Just Cut Their Smith Micro Software, Inc. (NASDAQ:SMSI) Revenue and EPS estimates

VRPX

Simply Wall St.

a year ago

Bearish: Analysts Just Cut Their Smith Micro Software, Inc. (NASDAQ:SMSI) Revenue and EPS estimates

CareMax, Inc. (NASDAQ:CMAX) Q3 2023 Earnings Call Transcript

VRPX

Insider Monkey

a year ago

CareMax, Inc. (NASDAQ:CMAX) Q3 2023 Earnings Call Transcript

Sadot Group Inc. Announces Third Quarter 2023 Conference Call

VRPX

ACCESSWIRE

a year ago

Sadot Group Inc. Announces Third Quarter 2023 Conference Call

Wood Pellet Exporter Enviva's Stock Is Tumbling Again

VRPX

The Wall Street Journal

a year ago

Wood Pellet Exporter Enviva's Stock Is Tumbling Again

VRPX

Associated Press Finance

a year ago

Aptose Biosciences: Q3 Earnings Snapshot

Kingstone Announces 2023 Third Quarter Financial Results

VRPX

ACCESSWIRE

a year ago

Kingstone Announces 2023 Third Quarter Financial Results

Cheetah Net Supply Chain Service Inc. Announces Third Quarter 2023 Results

VRPX

GlobeNewswire

a year ago

Cheetah Net Supply Chain Service Inc. Announces Third Quarter 2023 Results

Aptose Reports Results for the Third Quarter 2023

VRPX

GlobeNewswire

a year ago

Aptose Reports Results for the Third Quarter 2023

VRPX

GuruFocus.com

a year ago

CareMax Inc (CMAX) Reports Growth Amidst Challenges in Q3 2023

Rallybio Reports Third Quarter 2023 Financial Results and Provides Business Updates

VRPX

Business Wire

a year ago

Rallybio Reports Third Quarter 2023 Financial Results and Provides Business Updates

CareMax Reports Third Quarter 2023 Results

VRPX

Business Wire

a year ago

CareMax Reports Third Quarter 2023 Results

Acorda Third Quarter 2023 Update: Webcast/Conference Call Scheduled for November 13, 2023

VRPX

Business Wire

a year ago

Acorda Third Quarter 2023 Update: Webcast/Conference Call Scheduled for November 13, 2023

Acorda Therapeutics Announces Biopas Laboratories Submission to Regulatory Agencies in Six Latin American Countries for Approval of INBRIJA®

VRPX

Business Wire

a year ago

Latest Virpax Pharmaceuticals Inc. (VRPX) News on November 18, 2024

Share on Social Networks: